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Abstract: We have studied the effects of aging on fecal microbiota composition in the senescence-
accelerated prone mice SAMP8 strain. We compared animals 2, 4 and 6 months old. Feces were 
collected at the end of each period and a genomic study was carried out on fecal DNA using the 
Illumina MiSeq analyzer. The Shannon diversity index showed similar values along this period and 
the number of species was neither affected by aging. The phylum Verrucobacteria went up with 
age, showing a 7-fold increase at 6 months, compared to 2 months old mice. At family level, changes 
observed between 2 and 6 months of age involved significant increases in Bacteroidaceae (q < 0.001) 
and strong reductions in Lactobacillaceae (q < 0.0001) and Prevotellaceae (q < 0.05); at genus level, 
there was a significant reduction in probiotic Lactobacillus. At species level, we observed an age-
related reduction in Lactobacillus hayakitensis, a species involved in mucosal immune homeostasis, 
and in Blautia hansenii, which provides protection against Clostridium difficile infection. Interestingly, 
aging increases Parabacteroides goldsteiini, which is involved in the regulation of the TLR4 pathway. 
These results support the view that aging results in the proliferation of bacterial species that are 
associated with the immune deterioration of the gut mucosa. 
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1. Introduction 
The gut microbiota is a highly complex and diverse community of bacteria that closely interacts 
with the epithelium and the underlying immune cells in the gut [1]. The bacterial phyla that dominate 
the gut microbiota of different mammalian species are Bacteroidetes, Firmicutes, Actinobacteria and 
Proteobacteria [2,3]. In recent years, it has become clear that the gut microbiota has a major impact 
on the immune system, metabolism, and even behavior of the host [4]. Moreover, an imbalance in 
gut microbiota composition (dysbiosis) has been associated with several immunological, metabolic, 
and mental disorders [5]. 
Changes in the composition of the gut microbiota along aging likely contribute to 
immunosenescence and to the development of a pro-inflammatory phenotype [6]. In fact, elderly is 
more susceptible to infections and show a weaker immune protection after vaccination. Moreover, 
homeostasis between pro-inflammatory and regulatory responses is lost, which results in a state of 
low-grade chronic systemic inflammation, which is called inflammaging [7]. This age-related chronic 
inflammation likely contributes to the pathology of several diseases typically associated with aging 
such as dementia, stroke, and cardiovascular diseases. In addition, advanced age has been reported 
to increase intestinal permeability in rodents and non-human primates and may subsequently 
enhance translocation of luminal bacterial products and induce inflammation [8,9]. 
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Inflammaging can impair brain function by an increase in inflammatory cytokine expression and 
elevated oxidative stress, blood–brain barrier breakdown, peripheral immune cell infiltration, and 
glial cell activation. Our results with the SAM model support this view because we have 
demonstrated that this mice model shows impaired intestinal immune response [10] as well as certain 
neurodegeneration that impairs memory function [11]. 
Aging-associated alterations in gut physiology (i.e., gastric motility disorders, hypochlorhydria, 
degenerative changes in enteric nervous system, etc.) have profound effects on the diversity, 
composition and functional features of intestinal microbiome [12]. These age-related differences can 
appear, in particular, because long-term stimulation of immune system may cause 
immunosenescence. With that, appears inflammaging, which accompanies many aging-associated 
diseases, including both gastrointestinal and non-gastrointestinal pathological conditions such as 
atherosclerosis, frailty, cancer, fatty liver disease, metabolic syndrome, type 2 diabetes, 
neurodegenerative diseases, etc. [12–14]. 
In previous studies performed with SAMP8 mice model, we have observed that at 6 months of 
age, mice exhibit an impaired immune response in the intestinal mucosa characterized by nonspecific 
gut-associated lymphoid tissue activation and a weak specific immune response [10]. In addition, in 
the same mice model, we have observed a cognitive impairment associated to increased brain 
inflammatory state and with a reduced blood-brain barrier [11]. 
Because this mouse model shows several characteristics of the deterioration associated with 
aging, both at the intestinal and cerebral levels, our aim in this work has been to determine whether 
these changes could be associated with an alteration in the profile of the microbiota. 
2. Materials and Methods 
2.1. Animals 
Experiments were done in mice prone to senescence (SAMP8 strain), which were maintained 
and grown in the animal facility of the Facultat de Farmàcia i Ciències de l’Alimentació of the 
Universitat de Barcelona. Protocols used in this study were approved by the Animal Experimentation 
Ethics Committee (CEEA) of the Universitat de Barcelona, in accordance with the Generalitat de 
Catalunya’s guidelines for the Care and Use of Laboratory Animals (DAAM: 7939 and 9272). 
2.2. Aging Effect on Microbiome Composition 
We used SAMP8 mice 2, 4 and 6 months old (groups named 2M, 4M and 6M, respectively). 
Animals were maintained in conventional housing (3–4 animals per cage) until the age of 2 months, 
and from then they were kept in individual cages. 
2.3. Sample Obtention 
Feces were collected at three time points (2 months, 4 months and 6 months) in clean conditions 
and immediately frozen in liquid N2. Samples were maintained at −80°C until use. DNA was 
extracted following Moretó et al. [15]. 
2.4.16. S rDNA Gene Analysis 
The extracted genomic DNA was processed and the variable V3 and V4 regions of the 16S rRNA 
gene were amplified. The primers to detect 16S rRNA gene were: 16S forward 5′-
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3′ and reverse 5′ 
-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3′. High-
through sequencing was done using the Illumina MiSeq platform (Illumina, San Diego, CA, USA) at 
the Genomics and Bioinformatics Service, Universitat Autònoma de Barcelona (Bellaterra, Spain). 
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2.5. Statistics Analysis 
Results are presented as means ± SEM. The statistical analysis was performed using GraphPad 
Prism®  software v 8.02 (GraphPad Software, Inc., La Jolla, CA, USA). Grubb’s test was performed to 
determine outliers and the Shapiro-Wilk test was used to check the normality of data distribution. To 
compare 2M, 4M and 6M groups, the ANOVA test was used when data were normally distributed; 
otherwise the non-parametric Kruskal-Wallis test was carried out. All p-values were corrected for 
multiple testing using the false discovery rate (FDR) correction (Benjamini-Hochberg). Statistical 
differences were considered significant at q < 0.05. 
3. Results 
3.1. Shannon Diversity Index and the Number of Species 
The Shannon diversity index, which is commonly used to characterize species diversity in a 
community, was not changed by aging, nor was the number of species present in feces (Figure 1). 
 
Figure 1. Microbial Shannon’s index (A), number of species (B). Results are expressed as mean ± SEM 
(n = 11 mice). 
3.2. Phylum Level 
The most represented phyla were Firmicutes (F) and Bacteroidetes (B) and this did not change 
with age (Figure 2). Therefore, the F/B ratio was also similar in the three age groups, with mean values 
of 1.07 (2M); 0.98 (4M) and 0.82 (6M). However, the phylum Verrucomicrobia increased severalfold 
with aging respect to 2M (4M q = 0.004; 6M q = 0.045). 
 
Figure 2. Effects of aging on fecal bacterial composition (Phylum level) at 2M (A), 4M (B) and 6M (C). 
Results are expressed as percent of the total population at phylum level (mean) from 11 mice. 
3.3. Family Level Families 
At this taxonomic level there were changes in the relative presence of some between 2, 4 and 6 
months of age (2M, 4M and 6M, respectively; Figure 3). Four- and 6-months old mice showed 
increased relative abundance in Bacteroidaceae, Erysipelotrichaceae and Verrucomicrobiaceae (all q 
< 0.02). In contrast, both aged mice (4 and 6 months old) showed a pronounced reduction in the 
abundance of Prevotellaceae, Lactobacillaceae (both q < 0.001). Other families were also modified by 
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aging, smaller but significant reductions in Clostridiaceae and Helicobaceriaceae were also observed 
(all q < 0.05). 
 
Figure 3. Effects of aging on fecal bacterial composition at family level. Results are expressed as 
percent of the total population at family level (mean ± SEM; n = 10–11 mice). Statistical differences 
were considered. significant at q < 0.05 (corrected p values). 
3.4. Genus Level 
There were important changes with age in the abundance of a number of genera, most of which 
showed a relative reduction in their abundance (Lactobacillus, Prevotella, Flavobacterium, Helicobacter, 
Natronincola, Odoribacter, Pedobacter, Olivibacter, just to mention those with a 1% presence of the Genus 
level; all q < 0.05). Few genera (e.g., Bacteroides, Parabacteoides, Elysipelothrix, Butyricomonas, 
Akkermansia) showed an age-dependent increase (Table 1, q < 0.05). 
Table 1. Effects of aging on fecal bacterial composition at genus level. Results are expressed as percent 
of the total population at genus level (mean ± SEM; n = 10–11 mice). Statistical differences were 
considered significant at q < 0.05 (corrected p values). 
Phylum Family Genus 2M 4 M 6M 
Bacteroidetes 
Bacteroidaceae Bacteroides 11.1 ± 2.0 
a
 23.0 ± 2.5 
b




Pedobacter 1.75 ± 0.11 
a
 0.93 ± 0.08 
b
 1.00 ± 0.10 
b
 
Olivibacter 1.36 ± 0.19 
a
 0.77 ± 0.06 
b




Odoribacter 1.95 ± 0.31 
a
 0.15 ± 0.02 
b
 0.14 ± 0.02 
b
 
Butyricimonas 0.40 ± 0.07 
a
 1.32 ± 0.26 
b
 1.59 ± 0.28 
b
 
Prevotellaceae Prevotella 9.98 ± 2.40 
a
 0.98 ± 0.39 
b
 1.75 ± 0.40 
b
 
Porphyromonadaceae Parabacteroides 3.48 ± 0.45 
a
 3.44 ± 0.47 
a
 6.57 ± 0.89 
b
 
Flavobacteriaceae Flavobacterium 3.95 ± 0.65 
a
 1.10 ± 0.19 
b





Lactobacillus 8.85 ± 1.99 
a
 0.84 ± 0.34 
b
 1.15 ± 0.29 
b
 
Pediococcus 0.85 ± 0.18 
a
 0.14 ± 0.02 
b
 0.16 ± 0.03 
b
 
Lachnospiraceae Lachnospira 0.39 ± 0.06 
a
 0.10 ± 0.02 
b
 0.11 ± 0.04 
b
 
Erysipelotrichaceae Erysipelothrix 0.06 ± 0.01 
a
 3.34 ± 1.34 
b




Clostridium 1.53 ± 0.16 
a
 1.16 ± 0.12 
b
 0.92 ± 0.13 
c
 
Natronincola 2.46 ± 0.30 
a
 1.21 ± 0.30 
b
 0.92 ± 0.26 
b
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Proteobacteria 
Helicobacteraceae Helicobacter 3.92 ± 0.76 
a
 1.71 ± 0.34 
b
 1.53 ± 0.32 
b
 
Desulfovibrionaceae Desulfovibrio 1.53 ± 0.26 
a
 2.06 ± 0.36 
b
 3.10 ± 0.43 
b
 
Verrucomicrobia Akkermansiaceae Akkermansia 0.01 ± 0.00 
a
 2.38 ± 1.06 
b
 3.26 ± 1.50 
b
 
3.5. Specie Level 
Several species from genus Bacteroides increased with aging (q < 0.05; Table 2), while other 
members of the phylum Bacteroidetes decreased, such as Odoribacter denticanis and Prevotella dentasini 
(q < 0.05). Respect to Lactobacillaceae family, several members of the Lactobacillus genus were reduced 
during aging, as well as Pediococcus argentinicus (all q < 0.05). This behavior was also observed in two 
species included in the Lachnospiraceae family, Blautia hansenii and Johnsonella ignava (both, q < 0.05). 
Instead, it has been observed a notable increase in Desulfovibrio psychrotolerans and Akkermansia 
municiphila (both, q < 0.05), that belong to Proteobacteria and Verrucomicrobia phyla, respectively. 
Table 2. Effects of aging on fecal bacterial composition at specie level. Results are expressed as percent 
of the total population at specie level (mean ± SEM; n = 10–11 mice). Statistical differences were 
considered significant at q < 0.05 (corrected p values). 
Phylum Family Species 2M 4 M 6M 
Bacteroidetes 
Bacteroidaceae 
Bacteroides xylanisolvens 2.90 ± 0.45 
a
 7.94 ± 0.90 
b
 6.62 ± 1.16 
b
 
Bacteroides rodentium 2.74 ± 0.61 
a
 7.49 ± 1.52 
b
 3.16 ± 0.90 
a
 
Bacteroides acidifaciens 0.54 ± 0.11 
a
 5.94 ± 0.96 
b
 4.11 ± 0.70 
b
 
Bacteroides denticanum 0.86 ± 0.12 
a
 3.98 ± 1.36 
b
 6.55 ± 1.11 
c
 
Bacteroides sartorii 0.31 ± 0.07 
a
 1.26 ± 0.25 
b
 1.08 ± 0.29 
b
 
Bacteroides graminisolvens 0.17 ± 0.03 
a
 0.89 ± 0.12 
b




Odoribacter denticanis 2.57 ± 0.40 
a
 0.22 ± 0.06 
b
 0.20 ± 0.03 
b
 
Butyricimonas virosa 0.19 ± 0.03 
a
 1.30 ± 0.22 
b
 0.85 ± 0.20 
c
 
Prevotellaceae Prevotella dentasini 16.1 ± 3.73 
a
 1.12 ± 0.43 
b
 1.63 ± 0.40 
b
 
Porphyromonadaceae Parabacteroides gordonii 0.00 ± 0.00 
a
 0.01 ± 0.01 
a





Lactobacillus hayakitensis 5.13 ± 1.75 
a
 0.33 ± 0.13 
b
 0.86 ± 0.21 
b
 
Lactobacillus taiwanensis 1.93 ± 0.67 
a
 0.03 ± 0.01 
b
 0.06 ± 0.03 
b
 
Lactobacillus siliginis 1.77 ± 0.48 
a
 0.19 ± 0.07 
b
 0.28 ± 0.06 
b
 
Lactobacillus intermedius 0.85 ± 0.44 
a
 0.06 ± 0.02 
b
 0.11 ± 0.03 
b
 
Pediococcus argentinicus 0.45 ± 0.14 
a
 0.02 ± 0.01 
b




Blautia hansenii 1.68 ± 0.37 
a
 0.65 ± 0.07 
b
 0.95 ± 0.23 
b
 
Ruminococcus gnavus 0.24 ± 0.06 
a
 1.08 ± 0.29 
b
 0.64 ± 0.22 
ab
 
Johnsonella ignava 2.99 ± 0.56 
a
 0.31 ± 0.06 
b
 0.41 ± 0.11 
b
 
Erysipelotrichaceae Erysipelothrix muris 0.10 ± 0.02 
a
 5.54 ± 2.18
 b
 1.66 ± 0.83 
b
 
Ruminococcaceae Oscillospira guilliermondii 1.03 ± 0.12 
a
 1.82 ± 0.29 
b




Helicobacteraceae Helicobacter mastomyrinus 4.13 ± 0.64 
a
 1.21 ± 0.24 
b
 1.65 ± 0.50 
b
 
Desulfovibrionaceae Desulfovibrio psychrotolerans 0.26 ± 0.06 
a
 1.32 ± 0.58 
ab




Akkermansiaceae Akkermansia muciniphila 0.01 ± 0.00 
a
 7.17 ± 2.48 
b
 4.75 ± 2.20 
b
 
Verrucomicrobiaceae Luteolibacter algae 0.01 ± 0.00 
a
 1.86 ± 0.68 
b




Senescence is characterized by an increase in the basal inflammatory state, which contributes to 
the development and progression of various diseases associated with aging. This increase in the 
inflammatory state leads to a decrease in the functionality of the immune system and a reduced 
capacity to respond to the presence of infections or external aggressions, which is known as 
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immunosenescence [16]. In addition, this decrease in the immune system functionality is 
accompanied by low-intensity inflammation sustained over time, known as inflammaging, which is 
characterized by increased production of pro-inflammatory mediators and cytokines [17,18]. 
Dysbiosis observed during aging not only includes changes in the abundance of certain species 
and/or genera, which alone may already alter intestinal physiology, but pathogens may also appear. 
In the latter sense, the intestinal microbiota forms a stable community that reduces the invasion of 
non-native bacteria, because there is constant competition between normal bowel residents 
(commensals, mutualists and pathogens) [19]. 
In the microbiota of 6-month-old SAMP8 mice, the genera Bacteroides and Parabacteroides doubled 
in abundance. These results show the same pattern as that observed in a study of young and elderly 
individuals, where both genera accounted for 8–27% of the microbiome in a younger cohort, but more 
than 50% in the over 65 [20]. In addition, several studies have shown that the abundance of the genus 
Lactobacilli, which has generally been considered beneficial for intestinal health, decreases in the 
elderly [21]. In fact, lactobacillus loss is associated with fragility in the elderly [22]. In the 6-month 
SAMP8 mice from this study, a considerable loss in the abundance of different members of this genus 
was also observed, in line with studies performed in humans. 
In previous studies, we have shown that at 6 months of age, SAMP8 mice exhibit an impaired 
immune response in the intestinal mucosa characterized by nonspecific gut-associated lymphoid 
tissue activation and a weak specific immune response [10]. Really, the gastrointestinal tract of the 
elderly is particularly susceptible to infectious diseases, and this is associated with a lower 
responsiveness of the mucosal immune system [23]. In addition, several studies have shown that 
aging is associated with an alteration in the composition of the intestinal microbiota, which can 
aggravate intestinal inflammation and in turn increase intestinal permeability [24]. In fact, the 
microbiota of older adults is less diverse [22], and immunosenescence and physiological changes at 
the intestinal level due to age can destabilize the microbiota [25]. Recently, it has been observed that 
an ‘aged’ microbiota promotes immune dysfunction, including increased systemic inflammation and 
phagocytosis of macrophages, which can be partially restored by transferring the microbiota from 
young mice to aged mice [26]. 
SAMP8 mice at 6-month-old showed an impaired intestinal permeability that in turns promote 
intestinal inflammation. Moreover, SAMP8 mice showed increased abundance of Akkermansia and 
Proteobacteria that have been associated with intestinal inflammation and permeability [27]. In 
addition, increased abundance of Akkermansia and Desulfovibrio (that belongs to proteobacteria phylum) 
are associated intestinal inflammation induced by DSS [28]. Further studies indicate that Desulfovibrio 
can contribute to intestinal inflammation comes from observations that these bacteria are associated 
with the pathogenesis of inflammatory bowel disease [29,30]. In fact, it is not surprising that these two 
genera have been associated to intestinal inflammation since both altered mucus structure that was 
more penetrable by bacteria leading to increased intestinal immune infiltration [31,32]. 
Research in recent years has linked intestinal epithelial barrier dysfunction to various 
neurological disorders. In fact, increased age-related intestinal inflammation and permeability are 
thought to contribute to the pathogenesis of these neurological disorders [33]. In this sense, the 
intestinal-brain axis and the intestinal microbiota appear as key actors, as they form an integrated 
network in which the microbiota and the central nervous system communicate through endocrine, 
immune, and neuronal signaling pathways [34]. Several translational studies show that microbiota 
transfer from patients with neurological disorders, including autism, multiple sclerosis, and 
Parkinson’s disease, can influence behavior, motor dysfunction, and immune responses in different 
animal models [35–37]. 
It has been noted in gut of Alzheimer disease patients there is a decrease in the population of 
Firmicutes and an increase in the level of Bacteroidetes [38]. We did not observe a significant 
reduction in Firmicutes phylum, but we have observed a considerable reduction in several genera 
and species belonging to this phylum. In a similar manner, we also observed a huge increase in 
several species of Bacteroides that belongs to the Bacteroidetes phyla. These changes can be related 
to the increase in phosphorylated NF-κB, a transcription factor that promotes inflammatory 
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responses, observed in senescent SAMP8 mice, inducing neuroinflammation and memory loss [11]. 
In fact, Zhao and Lukiw [39] showed that LPS secreted by bacteria Bacteroides fragilis can activate the 
pro-inflammatory transcription factor NFκB in human primary microglial cells. Moreover, Cox et al., 
[34] found that Bacteroides correlates with aging and amyloid beta plaque deposition in brain of Tg 
2576 mice, a model of Alzheimer disease. 
SAMP8 mice, at 6 months of age, have also shown a sharp reduction in the Prevotellaceae family, 
which could also be related to the cognitive decline observed in these animals [11]. Several authors 
have also observed a similar reduction in this family in aged mice, which has been associated with 
neuropathology and Alzheimer’s disease [40]. In fact, a reduction of Prevotellaceae can alter mucin 
synthesis and therefore increase mucosal permeability, which would allow local and systemic 
exposure to bacterial endotoxin, which can lead to the accumulation of α-synuclein in the colon [41]. 
Aggregation-prone proteins such as β-amyloid and α-synuclein can propagate from the intestine to 
the brain and contribute to the pathogenesis of Parkinson’s disease, Alzheimer’s disease, and other 
neurodegenerative disorders [42]. 
On the other hand, SAMP8 mice showed a sharp reduction in the abundance of several species 
and genera belonging to Firmicutes phylum, such as Lactobacillus or Blautia, which are the main 
members of the Lactobacilliaceae and Lachnospiraceae families, respectively. These two genders 
have been found to be reduced in the elderly and this reduction has been linked to the development 
of Alzheimer’s disease [43,44]. Different strains of Lactobacillus produce acetylcholine and 
aminobutyric acid (γ-Aminobutyric acid, GABA) and improve learning and memory in aged rats 
suffering from D-galactose-induced Alzheimer’s disease [45], and the genus Blautia is positively 
correlated with a low inflammatory state and high cognitive scores [46]. 
Thus, we can conclude that in SAMP8 mice at 6 months of age a reduction of probiotic species 
is observed that modify the synthesis and secretion of neurotrophic factors, while the pro-
inflammatory species of the intestinal microbiota increase, which they are able to secrete bacterial 
amyloids and lipopolysaccharides, which are considered neurotoxic [47]. In these mice we have 
previously described a deterioration in the barrier function of the intestinal wall and the blood-brain 
barrier. Therefore, these endotoxins can penetrate from the intestinal cavity into the bloodstream and 
into brain tissue, where they would have a negative effect on the structure and functions of the CNS 
and promote neuroinflammation and neurodegeneration. 
5. Conclusions 
6-month-old SAMP8 mice already show fecal microbiota dysbiosis consistent with the reduced 
intestinal barrier integrity and impaired intestinal immune response previously observed. Both, the 
dysbiosis observed in this work and the intestinal permeability could be involved in the 
neuroinflammation and blood-brain-barrier reduction that would lead to the cognitive decline 
observed in these mice. 
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